01-08-2019 07:03 PM CET - Health & Medicine
Print

Early Dementia detection via App receives medical device status

Press release from: DST
The DST is available on Apple, Google, Amazon appstores.
The DST is available on Apple, Google, Amazon appstores.


- The DST (Dementia Screening Test) App has been recognized by Health Authorities as a Medical Device.
- Early Dementia stages are reliably detected, before the brain damages become irreversible.
- Sensitivity above 96%, significantly higher than with the established tests (e.g., MMSE 71%).

Dementia is a rapidly increasing social problem of a rapidly aging society. Because until today, there is no effective therapy for advanced stages of dementia. Therefore, effective screening concepts are needed, to detect early stages reliably across the population, and to start treatment before the brain damages become irreversible.

Demand for Dementia Screening Tests has increased significantly in recent years, as the focus of dementia research has changed from diagnosis and treatment at the clinically symptomatic stage, to pre-symptomatic neuroprotective therapies. Dementia should no longer be regarded as a disease of the elderly, but as one of middle-aged people which is clinically quiet for a long time. 1)

To detect the disease at this early stage, special sensitive tests are necessary, which are also widely used without any suspicion, to have an impact at population level as well as at an individual level. The classical questionnaire-based self-assessments are not very suitable, because they identify the disease only with existing symptoms and thus generally too late.

A group of physicians has therefore developed a simple, validated, and easily accessible Dementia test - the DST (Dementia Screening Test - www.demenz-test.com). The reliability of the test results especially in the asymptomatic pre-dementia stage has been proven by clinical studies. The test has therefore been recognized as a medical device by the competent authorities, including the EU, Switzerland, Iceland, Norway, Liechtenstein, Canada and Australia.

1) The Lancet Commission for Dementia prevention, intervention, and care (2017) 390: 2673–734: Dementia prevention, intervention, and care

Changing Dementia - that is the vision of the DST.
The DST was developed by a group of physicians to reliably detect early stages of Dementia, as a basis for treatment before obvious symptoms develop.

Dr. med. Sebastian Horn
Friedrichstr. 67
10117 Berlin, Germany

www.demenz-test.com

This release was published on openPR.
News-ID: 1480417 • Views: 277
More releasesMore releases

You can edit or delete your press release here: